The efficacy of tamsulosin 0.4 mg when tamsulosin 0.2 mg is insufficient for benign prostatic hyperplasia in Korean patients. [PDF]
Chung Y, Jeong SJ, Song SH, Hong SK.
europepmc +1 more source
A fixed dose combination of tamsulosin and tadalafil in men with benign prostatic hyperplasia and erectile dysfunction: a prospective, multicenter, phase IV study. [PDF]
Gupta C +13 more
europepmc +1 more source
Quantum Biochemistry Insights into Ligand Recognition at the a<sub>1A</sub>-Adrenoceptor. [PDF]
Talinne da Costa Gomes L +6 more
europepmc +1 more source
Correlation between intravesical prostatic protrusion and ejaculatory dysfunction after tamsulosin treatment in men with BPH. [PDF]
Gezmiş CT +5 more
europepmc +1 more source
Phosphodiesterase inhibitors for the management of lower urinary tract symptoms in men without benign prostatic hyperplasia: a systematic review. [PDF]
Bakhsh A +12 more
europepmc +1 more source
Doxazosin versus tamsulosin for the treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic literature review and network meta-analysis. [PDF]
Oelke M +4 more
europepmc +1 more source
Cardiovascular safety of 5α-reductase inhibitors in people with benign prostatic hyperplasia and type 2 diabetes: a propensity score-matched analysis. [PDF]
Tu H +7 more
europepmc +1 more source
Successful Treatment of Obstructive Ureterolithiasis with Medical Expulsive Therapy Including Tamsulosin in a Dog. [PDF]
Park C +5 more
europepmc +1 more source
Ningmitai capsule in patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, prospective, randomized, parallel, positive-controlled study. [PDF]
Gao J +14 more
europepmc +1 more source
Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis. [PDF]
Niaga KJK +7 more
europepmc +1 more source

